Compliance certificate under regulation 74(5) of SEBI ((DP) Regulation, 2018 for half year ended as on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma has submitted a routine compliance certificate to BSE under SEBI's Depository Regulations for the half year ending 30 September 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Accurate Securities & Registry Private Limited. It confirms that all physical share certificates received from depository participants for dematerialisation during this period were processed within the regulatory timeline. The physical certificates were duly cancelled and the depository's name has been substituted as the registered owner in the company's records. This is a standard half-yearly compliance obligation, not a material business event.
This is a routine regulatory filing with no material impact on the company's financials, operations, or shareholder value. It simply confirms that share dematerialisation activities are being handled in compliance with SEBI rules.